About Cenobamate
Arvelle Therapeutics is responsible for the development and commercialisation of cenobamate, an investigational anti-seizure medication, in the European market.
Arvelle Therapeutics is responsible for the development and commercialisation of cenobamate, an investigational anti-seizure medication, in the European market.
Press Releases and Events